ZIMVIE INC (ZIMV) Stock Fundamental Analysis
NASDAQ:ZIMV - Nasdaq - US98888T1079 - Common Stock - Currency: USD
Overall ZIMV gets a fundamental rating of 4 out of 10. We evaluated ZIMV against 189 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of ZIMV while its profitability can be described as average. ZIMV is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
ZIMV had positive earnings in the past year.
In the past year ZIMV had a positive cash flow from operations.
In the past 5 years ZIMV always reported negative net income.
In the past 5 years ZIMV always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of ZIMV (-2.62%) is better than 69.84% of its industry peers.
ZIMV has a Return On Equity of -4.94%. This is in the better half of the industry: ZIMV outperforms 71.43% of its industry peers.
The Return On Invested Capital of ZIMV (0.09%) is better than 65.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.62% | ||
| ROE | -4.94% | ||
| ROIC | 0.09% |
ROA(3y)-13.32%
ROA(5y)-10.87%
ROE(3y)-37.08%
ROE(5y)-25.96%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ZIMV has a better Operating Margin (0.17%) than 65.08% of its industry peers.
ZIMV has a Gross Margin of 64.83%. This is in the better half of the industry: ZIMV outperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of ZIMV has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.17% | ||
| PM (TTM) | N/A | ||
| GM | 64.83% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-1.34%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ZIMV is destroying value.
Compared to 1 year ago, ZIMV has more shares outstanding
The number of shares outstanding for ZIMV has been increased compared to 5 years ago.
Compared to 1 year ago, ZIMV has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.36, we must say that ZIMV is in the distress zone and has some risk of bankruptcy.
ZIMV has a Altman-Z score of 0.36. This is comparable to the rest of the industry: ZIMV outperforms 46.03% of its industry peers.
ZIMV has a debt to FCF ratio of 38.44. This is a negative value and a sign of low solvency as ZIMV would need 38.44 years to pay back of all of its debts.
The Debt to FCF ratio of ZIMV (38.44) is better than 69.84% of its industry peers.
A Debt/Equity ratio of 0.56 indicates that ZIMV is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.56, ZIMV is doing worse than 64.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 38.44 | ||
| Altman-Z | 0.36 |
ROIC/WACC0.01
WACC6.46%
2.3 Liquidity
A Current Ratio of 2.14 indicates that ZIMV has no problem at all paying its short term obligations.
The Current ratio of ZIMV (2.14) is worse than 63.49% of its industry peers.
A Quick Ratio of 1.48 indicates that ZIMV should not have too much problems paying its short term obligations.
ZIMV's Quick ratio of 1.48 is on the low side compared to the rest of the industry. ZIMV is outperformed by 61.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.14 | ||
| Quick Ratio | 1.48 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 81.40% over the past year.
Looking at the last year, ZIMV shows a very negative growth in Revenue. The Revenue has decreased by -55.80% in the last year.
Measured over the past years, ZIMV shows a very negative growth in Revenue. The Revenue has been decreasing by -15.69% on average per year.
EPS 1Y (TTM)81.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%237.5%
Revenue 1Y (TTM)-55.8%
Revenue growth 3Y-23.75%
Revenue growth 5Y-15.69%
Sales Q2Q%-5.24%
3.2 Future
The Earnings Per Share is expected to grow by 18.19% on average over the next years. This is quite good.
ZIMV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.49% yearly.
EPS Next Y44.36%
EPS Next 2Y23.34%
EPS Next 3Y18.19%
EPS Next 5YN/A
Revenue Next Year-0.32%
Revenue Next 2Y0.97%
Revenue Next 3Y1.49%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ZIMV is valuated reasonably with a Price/Earnings ratio of 11.22.
Based on the Price/Earnings ratio, ZIMV is valued cheaply inside the industry as 94.18% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.70. ZIMV is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 9.75, the valuation of ZIMV can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ZIMV indicates a rather cheap valuation: ZIMV is cheaper than 94.18% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.49, ZIMV is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.22 | ||
| Fwd PE | 9.75 |
4.2 Price Multiples
87.30% of the companies in the same industry are more expensive than ZIMV, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZIMV indicates a somewhat cheap valuation: ZIMV is cheaper than 75.66% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 42.45 | ||
| EV/EBITDA | 11.47 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ZIMV's earnings are expected to grow with 18.19% in the coming years.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y23.34%
EPS Next 3Y18.19%
5. Dividend
5.1 Amount
ZIMV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
8.75
-0.26 (-2.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners90.18%
Inst Owner Change-2.49%
Ins Owners1.93%
Ins Owner Change18.73%
Market Cap243.69M
Analysts48.89
Price Target17.63 (101.49%)
Short Float %1.79%
Short Ratio3.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.99%
Min EPS beat(2)1.94%
Max EPS beat(2)26.05%
EPS beat(4)4
Avg EPS beat(4)46.12%
Min EPS beat(4)1.94%
Max EPS beat(4)78.25%
EPS beat(8)7
Avg EPS beat(8)188.53%
EPS beat(12)10
Avg EPS beat(12)161.28%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.4%
Min Revenue beat(2)-3.62%
Max Revenue beat(2)-3.18%
Revenue beat(4)0
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-3.62%
Max Revenue beat(4)-0.2%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)3
Avg Revenue beat(12)-1.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.41%
PT rev (3m)-10.37%
EPS NQ rev (1m)-8.51%
EPS NQ rev (3m)11.21%
EPS NY rev (1m)-1.18%
EPS NY rev (3m)10.26%
Revenue NQ rev (1m)-2.5%
Revenue NQ rev (3m)-4.24%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)-1.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.22 | ||
| Fwd PE | 9.75 | ||
| P/S | 0.55 | ||
| P/FCF | 42.45 | ||
| P/OCF | 20.7 | ||
| P/B | 0.62 | ||
| P/tB | 5.41 | ||
| EV/EBITDA | 11.47 |
EPS(TTM)0.78
EY8.91%
EPS(NY)0.9
Fwd EY10.26%
FCF(TTM)0.21
FCFY2.36%
OCF(TTM)0.42
OCFY4.83%
SpS15.93
BVpS14.19
TBVpS1.62
PEG (NY)0.25
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.62% | ||
| ROE | -4.94% | ||
| ROCE | 0.12% | ||
| ROIC | 0.09% | ||
| ROICexc | 0.11% | ||
| ROICexgc | 0.28% | ||
| OM | 0.17% | ||
| PM (TTM) | N/A | ||
| GM | 64.83% | ||
| FCFM | 1.29% |
ROA(3y)-13.32%
ROA(5y)-10.87%
ROE(3y)-37.08%
ROE(5y)-25.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-1.34%
F-Score4
Asset Turnover0.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 38.44 | ||
| Debt/EBITDA | 6.25 | ||
| Cap/Depr | 17.47% | ||
| Cap/Sales | 1.36% | ||
| Interest Coverage | 0.05 | ||
| Cash Conversion | 33.36% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.14 | ||
| Quick Ratio | 1.48 | ||
| Altman-Z | 0.36 |
F-Score4
WACC6.46%
ROIC/WACC0.01
Cap/Depr(3y)17.11%
Cap/Depr(5y)24.69%
Cap/Sales(3y)2.37%
Cap/Sales(5y)3.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%237.5%
EPS Next Y44.36%
EPS Next 2Y23.34%
EPS Next 3Y18.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-55.8%
Revenue growth 3Y-23.75%
Revenue growth 5Y-15.69%
Sales Q2Q%-5.24%
Revenue Next Year-0.32%
Revenue Next 2Y0.97%
Revenue Next 3Y1.49%
Revenue Next 5YN/A
EBIT growth 1Y102.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year153.4%
EBIT Next 3Y42.66%
EBIT Next 5YN/A
FCF growth 1Y89.44%
FCF growth 3Y-0.91%
FCF growth 5Y-35.32%
OCF growth 1Y-56.92%
OCF growth 3Y-39.59%
OCF growth 5Y-34.68%